 | This article contains content that is written like an advertisement .(April 2021) |
Electron Kebebew | |
|---|---|
 | |
| Born | February 26, 1968 |
| Education | UCLA (B.S., 1991) UC San Francisco (M.D., 1995) |
| Spouse | Tida Violante |
| Children | 2 |
Electron Kebebew is an American surgeon, educator and scientist. Kebebew is currently the Harry A. Oberhelman Jr. and Mark L. Welton Professor and Chief of General Surgery at Stanford University.
Electron Kebebew was born in Addis Ababa, Ethiopia on February 26, 1968. [1] Kebebew graduated from the University of California, Los Angeles in 1991 with a B.S. in chemical engineering. In 1995, he graduated with a medicine degree from the University of California, San Francisco where he also went on to do his general surgery residency and postdoctoral fellowship.
He received a T32 NIH Surgical Oncology Fellowship [1] [2] during 1997–1999 [3] and worked in the endocrine oncology laboratory [4] of Drs. Orlo H. Clark and Quan-Yang Duh. After finishing his training in 2002, Kebebew became an assistant professor of surgery at UCSF. He established his research and continued to operate on hundreds of patients with endocrine tumors each year at the Endocrine Surgery and Oncology Clinic at the UCSF Diller Comprehensive Cancer Center.
In 2009, Kebebew became one of the handful of African American tenured senior investigators at the National Institutes of Health (NIH) [5] within the National Cancer Institute (NCI). Under the leadership of Harold E. Varmus, Kebebew became the inaugural Chief of the Endocrine Oncology Surgery Branch, overseeing $10 million in research each year. During his time at the NIH, Kebebew treated complicated cancer cases in thousands of patients from all over the world. [6] [7] The endocrine oncology surgery branch became an international model for educating surgeons to become researchers. His research laboratory at the NIH published hundreds of journal articles and produced dozens of scientists through the surgeon research training fellowship program. [6]
In 2018, Kebebew became the Chief of General Surgery [1] [8] and the Harry A. Oberhelman, Jr., and Mark L. Welton Professor of Surgery at Stanford University. [9] [8] He oversees the entire General Surgery Division, which includes colorectal surgery, minimally invasive and bariatric surgery, trauma/critical care and acute care surgery, surgical oncology (breast, gastrointestinal, hepatopancreaticobiliary, and endocrine surgery), and general surgery at the Veterans Affairs Palo Alto Health Care System. His research laboratory includes research fellows studying endocrine tumors.
As of 2020, he has published over 400 scientific articles, [10] as well as textbooks and chapters, opinion pieces, reviews, and newsletter articles. [11] His focus is on developing effective therapies for fatal, rare, and neglected endocrine cancers, identifying new methods, strategies, and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognosis of endocrine cancers, and developing methods for the precision treatment of endocrine tumors. His published works can be found on PubMed.gov.
In 2020, Kebebew became the Editor-in-Chief of the scientific journal Thyroid and has served on the editorial board and as a reviewer for 54 biomedical journals. [12]
Kebebew is a fellow of the American College of Surgeons, [13] a member of the American Thyroid Association, [14] American Association of Endocrine Surgeons, and the Society of Black Academic Surgeons. Kebebew is the Goodwill Ambassador for the nonprofit Ethiopia Reads, which promotes children’s literacy. [15]
Kebebew has received awards for his work from the American Cancer Society, American Association for Cancer Research, American Association of Endocrine Surgeons, [16] International Association of Endocrine Surgeons and the American Thyroid Association’s Van Meter Award. [9]
Otorhinolaryngology is a surgical subspeciality within medicine that deals with the surgical and medical management of conditions of the head and neck. Doctors who specialize in this area are called otorhinolaryngologists, otolaryngologists, head and neck surgeons, or ENT surgeons or physicians. Patients seek treatment from an otorhinolaryngologist for diseases of the ear, nose, throat, base of the skull, head, and neck. These commonly include functional diseases that affect the senses and activities of eating, drinking, speaking, breathing, swallowing, and hearing. In addition, ENT surgery encompasses the surgical management of cancers and benign tumors and reconstruction of the head and neck as well as plastic surgery of the face, scalp, and neck.
The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.
A thyroidectomy is an operation that involves the surgical removal of all or part of the thyroid gland. In general surgery, endocrine or head and neck surgeons often perform a thyroidectomy when a patient has thyroid cancer or some other condition of the thyroid gland or goiter. Other indications for surgery include cosmetic, or symptomatic obstruction. Thyroidectomy is a common surgical procedure that has several potential complications or sequelae including: temporary or permanent change in voice, temporary or permanently low calcium, need for lifelong thyroid hormone replacement, bleeding, infection, and the remote possibility of airway obstruction due to bilateral vocal cord paralysis. Complications are uncommon when the procedure is performed by an experienced surgeon.
Endocrine surgery is a surgical sub-speciality focusing on surgery of the endocrine glands, including the thyroid gland, the parathyroid glands, the adrenal glands, glands of the endocrine pancreas, and some neuroendocrine glands.
Lymphadenectomy, or lymph node dissection, is the surgical removal of one or more groups of lymph nodes. It is almost always performed as part of the surgical management of cancer. In a regional lymph node dissection, some of the lymph nodes in the tumor area are removed; in a radical lymph node dissection, most or all of the lymph nodes in the tumor area are removed.
Anaplastic thyroid cancer (ATC), also known as anaplastic thyroid carcinoma, is an aggressive form of thyroid cancer characterized by uncontrolled growth of cells in the thyroid gland. This form of cancer generally carries a very poor prognosis due to its aggressive behavior and resistance to cancer treatments. The cells of anaplastic thyroid cancer are highly abnormal and usually no longer resemble the original thyroid cells and have poor differentiation.
Papillary thyroid cancer is the most common type of thyroid cancer, representing 75 percent to 85 percent of all thyroid cancer cases. It occurs more frequently in women and presents in the 20–55 year age group. It is also the predominant cancer type in children with thyroid cancer, and in patients with thyroid cancer who have had previous radiation to the head and neck. It is often well-differentiated, slow-growing, and localized, although it can metastasize.
Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung, and the rest of the body.
Medullary thyroid cancer is a form of thyroid carcinoma which originates from the parafollicular cells, which produce the hormone calcitonin. Medullary tumors are the third most common of all thyroid cancers and together make up about 3% of all thyroid cancer cases. MTC was first characterized in 1959.
Parathyroid carcinoma is a rare cancer resulting in parathyroid adenoma to carcinoma progression. It forms in tissues of one or more of the parathyroid glands.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist, oncologist, and principal investigator. Before moving to the Icahn School of Medicine in 2013, he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy, treating patients with prostate, urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon, and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically, he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit; he is on such lists as America's Top Doctors, New York Magazine's Best Doctors, and Who's Who in the World. In 2012, he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology, most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
Thyroid cancer is cancer that develops from the tissues of the thyroid gland. It is a disease in which cells grow abnormally and have the potential to spread to other parts of the body. Symptoms can include swelling or a lump in the neck. Cancer can also occur in the thyroid after spread from other locations, in which case it is not classified as thyroid cancer.
Dr. Kodaganur S. Gopinath, MS, FAMS, FRCS (Edin) is an Indian surgical oncologist, known for his pioneering work on oncological research. He is a recipient of many awards including Dr. B. C. Roy Award, considered to be the premier medical honour in the country. The President of India recognised his services to the field of oncology, by awarding him the fourth highest civilian award, Padma Shri, in 2010.
Nadine Rena Caron FACS, FRCSC,, is a Canadian surgeon. She is the first Canadian female general surgeon of First Nations descent (Ojibway), as well as the first female First Nations student to graduate from University of British Columbia's medical school.
Laura Esserman is a surgeon and breast cancer oncology specialist. She is the director of the Carol Franc Buck Breast Care Center at the University of California, San Francisco School of Medicine. She leads the I-SPY trials, Athena Breast Health Network and the WISDOM study. Esserman is an inductee in the Giants of Cancer Care, 2018, for Cancer Diagnostics and the "less is more" approach. She performs live in the show "Audacity" which she co-created. She is also known as the "singing surgeon" for singing to her patients as they go under anesthesia.
UCSF Helen Diller Family Comprehensive Cancer Center is an NCI-designated Cancer Center, affiliated with the UCSF School of Medicine and the UCSF Medical Center. It is one of 69 cancer research institutions in the United States supported by the National Cancer Institute, and one of three in Northern California. The HDFCCC integrates basic and clinical science, patient care, and population science to address prevention and early detection of cancer as well as the quality of life following diagnosis and treatment.
Julie Ann Sosa is a professor and chair of the Department of Surgery at the University of California, San Francisco (UCSF) and holds the Leon Goldman, MD, Distinguished Professorship in Surgery. She currently serves as the Treasurer of the American Thyroid Association and Editor-in-Chief of the World Journal of Surgery.
The American Association of Endocrine Surgeons (AAES) is a professional organization for endocrine surgeons. The organization partakes in patient care, education, and scientific investigations in the field of endocrine surgery, including training endocrine surgeons and developing practice guidelines.
Evan Dale Abel is an American endocrinologist who serves as Chair of the Department of Medicine at the David Geffen School of Medicine at UCLA. His works on the molecular mechanisms that underpin cardiac failure in diabetes. He is a Fellow of the American Heart Association and the American College of Physicians. He was elected a member of the National Academy of Sciences in 2022.
Martha A. Zeiger is an American endocrine surgeon and scientist. She is currently Director of the Center for Cancer Research Office of Surgeon-Scientist Career Development at the National Institutes of Health (NIH). She is also an adjunct investigator in the Surgical Oncology Program at NIH's National Cancer Institute, where she previously served as director. She was the S. Hurt Watts Professor and Chair of the Department of Surgery at the University of Virginia. Prior to joining academia, Zeiger spent six years in the United States Navy as General Medical Officer, Commander and Surgeon in San Diego, Hawaii and Washington, D.C.
| International | |
|---|---|
| National | |
| Academics | |
